Tag:
H3 Bioscience
Latest Headlines
Latest Headlines
Eisai opens doors at $200M cancer drug R&D shop
After committing $200 million to the personalized cancer R&D unit, Japanese drugmaker Eisai officially opened the doors of the group, called H3 Biomedicine, in Cambridge, MA, this week. H3
